Veterinary Medicines

Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats

Authorised
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Download as PDF

Product identification

Medicine name:
Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Nobivac Tricat Trio injektiokuiva-aine, kylmäkuivattu ja liuotin, suspensiota varten
Active substance:
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain MW-1, Live
    4.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Felid herpesvirus 1, strain G2620A, Live
    5.20
    log10 plaque forming unit(s)
    /
    1.00
    Dose
  • Feline calicivirus, strain F9, Live
    4.60
    log10 plaque forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • (ID4) 50 Dose; 50 millilitre(s): Box (Cardboard) with 50 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID2) 10 Dose; 10 millilitre(s): Box (Cardboard) with 10 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID1) 5 Dose; 5 millilitre(s): Box (Cardboard) with 5 Box (Cardboard) each with 1 Bottle (Glass) with 1 millilitre(s) and 1 Bottle (Glass) with 1 Dose
  • (ID3) 25 Dose; 25 millilitre(s): Box (Cardboard) with 25 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID8) 50 Dose; 50 millilitre(s): Box (Kunststoff) with 50 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID7) 25 Dose; 25 millilitre(s): Box (Kunststoff) with 25 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID6) 10 Dose; 10 millilitre(s): Box (Kunststoff) with 10 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID5) 5 Dose; 5 millilitre(s): Box (Kunststoff) with 5 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 22805
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0240/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

2603424-paren-20251101.pdf

English (PDF)
Published on: 27/11/2025
Download